Kidney transplantation for a patient with refractory childhood-onset ANCA-associated vasculitis

Mod Rheumatol. 2016;26(2):307-9. doi: 10.3109/14397595.2013.877327. Epub 2014 Mar 19.

Abstract

A 14-year-old Japanese girl was admitted to our institution for the evaluation of renal dysfunction. Her serum creatinine was 1.1 mg/dL, proteinuria was 1.5 g/day, the urine sediment contained numerous erythrocytes per high-power field, and she was positive for myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA). Proteinuria was first noted at the age of 12 years. Renal biopsy showed crescentic glomerulonephritis with slight immunoglobulin A (IgA) deposition. A diagnosis of ANCA-associated vasculitis was made. Immunosuppressive therapy was initiated, including steroid pulse therapy and intravenous cyclophosphamide pulse therapy, but hemodialysis was required after 6 years. Eight months after the patient became anuric and her MPO-ANCA titer became negative, living-related donor kidney transplantation was done from her mother. ANCA became slightly positive 2 years later, but the patient remains stable without proteinuria or hematuria at 4 years after surgery. This case suggests that kidney transplantation can be performed successfully for a patient with refractory childhood-onset ANCA-associated vasculitis, and that remission of vasculitis associated with ANCA negativity at transplantation may contribute to a better renal prognosis in this patient.

Keywords: ANCA-associated vasculitis; anti-neutrophil cytoplasmic antibody; childhood onset; kidney transplantation; microscopic polyangiitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / surgery*
  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Female
  • Humans
  • Kidney Function Tests
  • Kidney Transplantation*
  • Peroxidase / immunology
  • Proteinuria / immunology
  • Proteinuria / surgery*
  • Treatment Outcome

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Peroxidase